Information For Readers

Biomolecules and Biomedicine (formerly BJBMS) is а premier venue for discoveries in basic and clinical biomedical science. Biomolecules and Biomedicine was founded in 1998 and is published by the Association of Basic Medical Sciences, a nonprofit honor organization of physician-scientists.

Broad readership and scope. Biomolecules and Biomedicine reaches readers across a wide range of medical disciplines and sectors. The journal publishes basic and translational/clinical research submissions and reviews in all biomedical specialties, including Genetics and Molecular biology, Immunology, Microbiology, Pathology, Biochemistry, Pharmacology, Anatomy, Biomaterials, New and Emerging Research and Diagnostic Methods, New and Emerging Medical Entities, and others.

Open access. All research is available to the public for free. Biomolecules and Biomedicine deposits published articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements.

Editorial Board. Renowned international experts in the journal's Editorial Board, together with external peer-reviewers select the best of the submissions for publication.


Sources: PubMed Central, Journal Citation Reports (Clarivate Analytics), Google Scholar, CiteScore (Scopus)

High visibility

  • Open Access: articles are freely available to readers immediately after publication.
  • Highly accessed online content: more than 200,000 visits/month (80,000 at PubMed Central (December 2022); 50,000 at the Journal's website (November 2022); more than 80,000 at Web of Science, Scopus, Google Scholar, and others).
  • Newsletters: more than 50,000 registered users receive a newsletter tailored to their field of interest.
  • Social media: articles are promoted through various social media channels (Twitter, LinkedIn, Facebook)
  • Advanced online: all accepted articles are published Advanced online and Ahead of print on PubMed within 3 days of acceptance, with citable DOIs, to make the article accessible as fast as possible.
  • Print circulation: 300 copies of print issues are sent to major libraries, institutes, universities, conferences, and subscribers across the globe. Get the free sample copy here.
  • BiomolBiomed Viewpoints: Journal's blog that promotes authors and their research by publishing plain language summaries for wide audience and media, as well as commentaries, interviews, news and stories related to science and research.

Indexing and abstracting

Timely publication

The 2023 peer review performance metrics:

  • Average time from submission to initial decision on rejection or peer review: 2 days
  • Average peer-review time and decision: 21 days
  • Average time from acceptance to (advanced online) publication: 1 day
  • Rejections without peer review: 40%
  • Acceptance Rate: 20%

Meaningful metrics

The success of the articles published in Biomolecules and Biomedicine is tracked in real-time by individualized Article-Level Metrics (Dimensions and PlumX). These reflect the viewership, download rates, social sharing, citations, field citation ratio, and relative citation ratio for each published article in a real-time, and help you illustrate the impact of your research

Journal Impact Factor® (JCR/Clarivate Analytics):

  • 2022 = 3.4
  • 2021 = 3.759
  • 2020 = 3.363
  • 2019 = 2.050
  • 2018 = 1.458
  • 2017 = 1.432
  • 2016 = 0.906
  • 2015 = 0.652
  • 2014 = 0.443

CiteScore® (SCOPUS/Elsevier)

  • 2023 = Check the latest CiteScore
  • 2022 = 5.3 (#143/830  82nd percentile)
  • 2021 = 5.20
  • 2020 = 4.00
  • 2019 = 3.20
  • 2018 = 1.43
  • 2017 = 1.31
  • 2016 = 0.94
  • 2015 = 0.78
  • 2014 = 0.59

BiomolBiomed Viewpoints: https://blog.bjbms.org

  • Publishes non-technical author's summaries for media and wide non-expert audience to promote the author's findings and research
  • Publishes interviews with experts
  • Publishes commentaries